• 1
    Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:4451.
  • 2
    Wenzel SE, Busse WW; the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:1421.
  • 3
    Dolhnikoff M, Da Silva LF, De Araujo BB, Gomes HA, Fernezlian S, Mulder A et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol 2009;123:10901097.
  • 4
    Burgel PR, De Blic J, Chanez P, Delacourt C, Devillier P, Didier A et al. Update on the roles of distal airways in asthma. Eur Respir Rev 2009;18:8095.
  • 5
    Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001;95:703719. Review.
  • 6
    Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000;106:12091226.
  • 7
    Cohen J, Douma WR, Ten Hacken NH, Vonk JM, Oudkerk M, Postma DS. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008;31:12131220.
  • 8
    Global INitiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda, MD: National Heart, Lung and Blood Institute, Updated 2006.
  • 9
    Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007;62:11821188.
  • 10
    Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007;29:682689.
  • 11
    Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther 2007;20:290303.
  • 12
    Nicolini G, Scichilone N, Bizzi A, Papi A, Fabbri LM. Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations. Ther Clin Risk Manag 2008;4:855864.
  • 13
    Fabbri LM, Nicolini G, Olivieri D, Papi A. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. Expert Opin Pharmacother 2008;9:479490.
  • 14
    Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 2009;103:4149.
  • 15
    Battaglia S, Den Hertog H, Timmers MC, Lazeroms SP, Vignola AM, Rabe KF et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005;60:639644.
  • 16
    In‘t Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000;161:19021906.
  • 17
    Bourdin A, Paganin F, Prefaut C, Kieseler D, Godard P, Chanez P. Nitrogen washout slope in poorly controlled asthma. Allergy 2006;61:8589.
  • 18
    Sterk PJ, Fabbri LM, Quarnier PhH, Cockcroft DW, O’Byrne PM, Anderson SD et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;6(Suppl. 16):5383.
  • 19
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. Respir Med 2005;99:850855.
  • 20
    Goldin JG, Tashkin DP, Kleerup EC, Greaser LE, Haywood UM, Sayre JW et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999;104:S258S267.
  • 21
    Hauber H, Taha R, Bergeron C, Migounov V, Hamid Q, Olivenstein R. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Can Respir J 2006;13:7378.
  • 22
    Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med 2004;15:170.
  • 23
    Thongngarm T, Silkoff PE, Kossack WS, Nelson HS. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma. J Asthma 2005;42:257263.
  • 24
    Gardini G, Corda L, Guerini M, La Piana GE, Taranto Montemurro L, Tantucci C. Effect on small airway obstruction of two different long-term LABA+ics treatments in asthmatic patients. Eur Respir J 2009;34(Suppl. 53):P1985.
  • 25
    Currie GP, Stenback S, Lipworth BJ. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. Br J Clin Pharmacol 2003;56:1117.
  • 26
    Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:5999.
  • 27
    Yamaguchi M, Niimi A, Ueda T, Takemura M, Matsuoka H, Jinnai M et al. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther 2009;22:326332.